Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer

Human epidermal growth factor receptor 2 (HER2)-positive breast cancer has a high metastatic potential. Monoclonal antibodies (mAbs) that target HER2, such as trastuzumab and pertuzumab, are the cornerstone of adjuvant therapy for HER2-positive breast cancer. A growing body of preclinical and clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feifei, Liu, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806173/
https://www.ncbi.nlm.nih.gov/pubmed/36601109
http://dx.doi.org/10.3389/fimmu.2022.1083462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806173/
https://www.ncbi.nlm.nih.gov/pubmed/36601109
http://dx.doi.org/10.3389/fimmu.2022.1083462

Ejemplares similares